Ellen Wiegner, MD
- Specialty: Radiation Oncology
-
Location:UH Seidman Avon Health Center
2075 Healthway Dr
Avon, OH 44011
- Call: 440-517-9013
Biography: Ellen Wiegner, MD
Expertise
Certifications & Memberships
- Radiation Oncology - American Board of Radiology
Education
Residency | Radiation Oncology
Radiation Oncology - Stanford Hospital And Clinics (2008 - 2012)
Internship | Internal Medicine
Internal Medicine - Stanford Hospital And Clinics (2007 - 2008)
Medical Education
Stanford University School Of Medicine (2003 - 2007)
Undergraduate
Gustavus Adolphus College (2002)
About
Ellen Wiegner, MD, is a board-certified radiation oncologist with extensive experience in treating many types of cancer with a special interest in breast and gastrointestinal cancers, including colorectal, esophageal, pancreatic, hepatobiliary and anal cancers. Her areas of technical expertise include adaptive radiotherapy, stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), 3D-conformal radiation therapy (3D-CRT) and brachytherapy.
Dr. Wiegner joined University Hospitals Seidman Cancer Center in December 2024. Prior to joining University Hospitals, she was a radiation oncologist at Dignity Health in Northern California.
Dr. Wiegner earned her medical degree from Stanford University School of Medicine (Stanford, California) in 2007. She went on to complete an internship in internal medicine and a residency in radiation oncology at Stanford University Medical Center in 2008 and 2012, respectively.
Among other awards and honors, Dr. Wiegner is the recipient of the American Brachytherapy Society HDR Brachytherapy Scholarship Award, 2013; Malcolm Bagshaw Outstanding Resident Award Recipient, Stanford University, 2012; and Chief Resident, Department of Radiation Oncology, Stanford University, 2011. She has published a number of medical abstracts and articles in the area of radiation oncology. Peer-reviewed medical journals in which her work appears include International Journal of Radiation Oncology, Biology, Physics; Practical Radiation Oncology; Expert Review of Anticancer Therapy; Diseases of the Esophagus; and Pediatric Blood & Cancer.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Ellen Wiegner did not disclose any Outside Relationships with Industry.